Skip to Main Content

Paper Details

A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
J Hematol Oncol
28
2014

Datasets